The FDA plans to create a Science Board subcommittee that will advise the Center for Devices and Radiological Health on strategies for advancing regulatory science. The subpanel will evaluate three medtech regulatory science domains, look at progress made by the FDA since 2007 and consider the issues presented by scientific and technological advances.

Related Summaries